Meridian Contrarian Fund Legacy Class MVALX

Morningstar Medalist Rating
  • NAV / 1-Day Return$41.10  /  −0.96%
  • Fund Size$568.6M
  • Adjusted Expense Ratio1.180%
  • Net Expense Ratio1.170%
  • Fee Level: DistributionAbove Average
  • Share Class TypeNo Load
  • Morningstar CategorySmall Blend
  • Equity Style Box (Funds)Small Blend
  • Minimum Initial Investment$1,000
  • Investment StatusClosed
  • TTM Yield0.29%
  • Turnover Ratio53%

Morningstar’s Analysis MVALX

Will MVALX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Meridian Contrarian Legacy holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MVALX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings20.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Goldman Sachs FS Government Instl

9.2355M
Cash and Equivalents

Texas Capital Bancshares Inc

2.4114M
Financial Services

Neogen Corp

2.4014M
Healthcare

First Citizens BancShares Inc Class A

2.2413M
Financial Services

International Flavors & Fragrances Inc

2.0112M
Basic Materials

BioMarin Pharmaceutical Inc

1.9412M
Healthcare

Ralliant Corp

1.9412M
Technology

Cameco Corp

1.9011M
Energy

Coeur Mining Inc

1.8811M
Basic Materials

Teleflex Inc

1.8311M
Healthcare

Sponsor Center